Skip to main content
. 2017 Mar 6;8(5):486–491. doi: 10.1021/acsmedchemlett.6b00391

Table 2. Selected SAR of Amino-Furazan (4).

graphic file with name ml-2016-00391h_0008.jpg

          in vitro ADME
calculated propertiesb and ligand efficiency metrics
Cmpd X R IDO IC50 (nM) HeLa IC50 (nM) P2 Cla P1 + P2 Cla Caco2 Pmc FF (%)d PSAe cLogP HBD HBAf MW LEg LLEg
4a Br OMe 200 100 >2.2 >2.2 44 0.9 100 2.7 3 8 374 0.45 4.3
4b Br OH 170 22 >2.2 >2.2 31 2.3 111 1.8 4 8 360 0.51 5.8
4c Br NH2 290 98 1.1 0.9 1.8 6.1 117 2.0 5 8 359 0.47 5.0
4d Br NHAc 210 17 0.9 2.0 19 4.4 120 1.9 4 9 401 0.45 5.9
4e Br NHSO2Me 100 16 0.7 1.5 24 2.4 137 2.0 4 10 437 0.44 5.8
4f Br NHSO2NH2 73 7.4 0.4 0.7 4.0 3.1 163 1.5 6 11 438 0.46 6.6
4g Cl NHSO2NH2 120 11 0.5 0.8 4.3 3.8 163 1.4 6 11 394 0.45 6.6
a

Rat IntCl (L/h/kg). Rat hepatic blood flow = 3.3 L/h/kg.

b

ChemDraw Ultra 10.

c

Caco2 values Pm × (10)−6 cm/s.

d

Protein binding free fraction (FF).

e

PSA in Å2.

f

Total number of nitrogen (N) and oxygens (O).

g

Ligand efficiency (LE) and lipophilic ligand efficiency (LLE) calculated using HeLa pIC50.